Some but not all neonates are affected by prenatal exposure to serotonin reuptake inhibitor
antidepressants (SRI) and maternal mood disturbances. Distinguishing the impact of these 2 …

Background Maternal mood disorders and their treatment during pregnancy may have
effects on the offspring epigenome. We aim to evaluate associations of maternal prenatal …

Despite the high prevalence of depression, anxiety, and use of antidepressant medications
during pregnancy, there is much uncertainty around the impact of high levels of distress or …

Prenatal exposure both to maternal psychiatric illness and psychiatric medication has been
linked with adverse child outcomes that affect physiological, emotional and psychiatric …

Studies assessing associations between prenatal exposure to antidepressants, maternal
depression, and offspring DNA methylation (DNAm) have been inconsistent. Here, we …

Antenatal corticosteroids (ACS) are used to treat women at risk of preterm birth to improve
neonatal survival. Though affected children may be at long-term risk of neurobehavioural …

Selective serotonin reuptake inhibitors (SSRIs) for treatment of prenatal maternal depression
have been associated with neonatal neurobehavioral disturbances, though the molecular …

Evidence in humans and rodents suggests that perinatal exposure to selective serotonin
reuptake inhibitor (SSRI) antidepressants can have serious long‐term consequences in …

When used during pregnancy, analgesics and psychotropics pass the placenta to enter the
foetal circulation and may induce epigenetic modifications. Where such modifications occur …

Context Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants
and maternal depression both alter neonatal health, and distinguishing the effects of each …